REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Pharmosa Biopharm Inc. (Taiwan, China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Pharmosa Biopharm Inc. Profile Updated: May 29, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Pharmosa Biopharm Inc. is a biotechnology company focusing on developing a new drug by exploiting our proprietary formulation and manufacturing technology. The main products of company include the development of drug-device combination product through 505(b)2 or hybrid regulatory pathway, applying our proprietary liposome technology to create the innovative nanoparticle formulation with existing drug. The company was established in 2000 and is headquartered in Taipei City, Taiwan.

Headquarters
3F.-3, No. 66, Sanchong Rd, Nangang Dist
Taipei City; Taipei City;

Contact Details: Purchase the Pharmosa Biopharm Inc. report to view the information.

Website: http://www.pharmosa.com.tw

Basic Information
Total Employees:
Purchase the Pharmosa Biopharm Inc. report to view the information.
Outstanding Shares:
Purchase the Pharmosa Biopharm Inc. report to view the information.
Financial Auditors:
Purchase the Pharmosa Biopharm Inc. report to view the information.
Incorporation Date:
May 25, 2000
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
8.34%
Purchase this report to view the information.
7.71%
Purchase this report to view the information.
6.3%
Purchase this report to view the information.
2.53%
Purchase this report to view the information.
2.01%
Subsidiaries
Pharmosa Therapeutics, Inc. (United States)
100%
Company Performance
Financial values in the chart are available after Pharmosa Biopharm Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Operating profit (EBIT)
-3.85%▼
EBITDA
-4.06%▼
Net Profit (Loss) for the Period
14.76%▲
Total assets
202.66%▲
Total equity
213.16%▲
Return on Equity (ROE)
14.97%▲
Debt to Equity Ratio
6.05%▲
Quick Ratio
-2.68%▼
Cash Ratio
-2.25%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo